/Eli%20Lilly%20and%20Co_%20by%20Sergio%20Photone%20via%20Shutterstock.jpg)
Investors are glued to Eli Lilly (LLY) shares this morning as the pharmaceutical behemoth became the world’s first trillion-dollar healthcare company.
LLY has soared this year on the back of explosive demand for its obesity (Zepbound) and diabetes (Mounjaro) treatments, which together brought in over $10 billion in the company’s latest reported quarter.